H.R. 3991 — Introduced in House

I 115th CONGRESS 1st Session H. R. 3991 IN THE HOUSE OF REPRESENTATIVES October 6, 2017Ms. Michelle Lujan Grisham of New Mexico introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend section 303(g)(2) of the Controlled Substances Act to allow certain pharmacists to dispense narcotic drugs for maintenance or detoxification treatment pursuant to the same waiver provisions as apply with respect to nurse practitioners and physician assistants. 1. Short title This Act may be cited as the Expanded Access to Opioid Abuse Treatment Act of 2017. 2. Eligibility of certain pharmacists for waivers for dispensing narcotic drugs for maintenance or detoxification treatment Section 303(g)(2)(G)(iv) of the Controlled Substances Act (21 U.S.C. 823(g)(2)(G)(iv)) is amended— (1) by striking nurse practitioner or physician assistant each place it appears and inserting nurse practitioner, physician assistant, or pharmacist; and (2) in subclause (II)(aa), by inserting the American Pharmacists Association, before or any other organization.